Simone Mader

4.6k total citations
39 papers, 2.8k citations indexed

About

Simone Mader is a scholar working on Neurology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Simone Mader has authored 39 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 18 papers in Pathology and Forensic Medicine and 14 papers in Immunology. Recurrent topics in Simone Mader's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (17 papers) and Systemic Lupus Erythematosus Research (11 papers). Simone Mader is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (17 papers) and Systemic Lupus Erythematosus Research (11 papers). Simone Mader collaborates with scholars based in Germany, Austria and United States. Simone Mader's co-authors include Lior Brimberg, Markus Reindl, Thomas Berger, Roman Sankowski, Kathrin Schanda, Betty Diamond, Hans Lassmann, Monika Bradl, Tatsuro Misu and Kazuo Fujihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Simone Mader

39 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Mader Germany 23 1.6k 1.6k 740 532 490 39 2.8k
Kathrin Schanda Austria 23 1.6k 0.9× 1.7k 1.1× 560 0.8× 588 1.1× 422 0.9× 46 2.8k
Takuya Matsushita Japan 33 1.7k 1.0× 1.6k 1.0× 680 0.9× 478 0.9× 783 1.6× 126 3.4k
B. Mark Keegan United States 31 2.0k 1.2× 2.0k 1.3× 653 0.9× 279 0.5× 469 1.0× 96 3.4k
Andreas Lutterotti Austria 29 1.7k 1.0× 973 0.6× 512 0.7× 274 0.5× 395 0.8× 79 2.9k
Elisabetta Capello Italy 27 1.3k 0.8× 641 0.4× 263 0.4× 441 0.8× 487 1.0× 75 2.5k
Raffaele Iorio Italy 32 1.0k 0.6× 1.7k 1.1× 294 0.4× 181 0.3× 438 0.9× 126 2.9k
Paola Perini Italy 22 1.8k 1.1× 769 0.5× 532 0.7× 288 0.5× 314 0.6× 68 2.4k
CH Polman Netherlands 24 2.2k 1.4× 853 0.5× 620 0.8× 206 0.4× 404 0.8× 50 3.0k
Dorothée Chabas United States 24 1.4k 0.9× 698 0.4× 587 0.8× 140 0.3× 608 1.2× 36 2.8k
Šarlota Mesaroš Serbia 28 1.8k 1.1× 622 0.4× 444 0.6× 253 0.5× 303 0.6× 95 2.4k

Countries citing papers authored by Simone Mader

Since Specialization
Citations

This map shows the geographic impact of Simone Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Mader more than expected).

Fields of papers citing papers by Simone Mader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Mader. The network helps show where Simone Mader may publish in the future.

Co-authorship network of co-authors of Simone Mader

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Mader. A scholar is included among the top collaborators of Simone Mader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Mader. Simone Mader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boldrini, Vinícius, et al.. (2025). Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders. Multiple Sclerosis and Related Disorders. 95. 106311–106311. 2 indexed citations
2.
Winklmeier, Stephan, Heike Rübsamen, Paul R. Wratil, et al.. (2024). Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva. Frontiers in Immunology. 15. 1330864–1330864. 4 indexed citations
3.
Mader, Simone, Stephan Winklmeier, Heike Rübsamen, et al.. (2023). Dissection of complement and Fc-receptor-mediated pathomechanisms of autoantibodies to myelin oligodendrocyte glycoprotein. Proceedings of the National Academy of Sciences. 120(13). e2300648120–e2300648120. 8 indexed citations
4.
Oswald, Eva, Atay Vural, Vuslat Yılmaz, et al.. (2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(2). 13 indexed citations
5.
Mader, Simone, Lior Brimberg, An Vo, et al.. (2022). In utero exposure to maternal anti–aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring. Science Translational Medicine. 14(641). eabe9726–eabe9726. 10 indexed citations
6.
Winklmeier, Stephan, Katharina Eisenhut, Heike Rübsamen, et al.. (2021). Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG. iScience. 25(1). 103659–103659. 20 indexed citations
7.
Beltrán, Eduardo, Manuela Paunovic, Romana Höftberger, et al.. (2020). Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis. Acta Neuropathologica. 141(1). 67–83. 12 indexed citations
8.
Drulović, Jelena, Irena Dujmović, Šarlota Mesaroš, et al.. (2019). Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia. Multiple Sclerosis and Related Disorders. 36. 101413–101413. 15 indexed citations
9.
Fujieda, Yuichiro, Simone Mader, Venkatesh Jeganathan, et al.. (2018). Clinical significance of anti‐DNA/N‐methyl‐D‐aspartate receptor 2 antibodies in de novo and post‐steroid cases with neuropsychiatric systemic lupus erythematosus. International Journal of Rheumatic Diseases. 22(3). 443–448. 4 indexed citations
10.
Mader, Simone, Lior Brimberg, John Soltys, Jeffrey L. Bennett, & Betty Diamond. (2018). Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport. Frontiers in Immunology. 9. 1599–1599. 5 indexed citations
11.
Mader, Simone, Lior Brimberg, & Betty Diamond. (2017). The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment. Frontiers in Immunology. 8. 1101–1101. 49 indexed citations
12.
Honig, Gerard, Simone Mader, Huiyi Chen, et al.. (2016). Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus Nerve. PLoS ONE. 11(1). e0144215–e0144215. 13 indexed citations
13.
Zeka, Bleranda, Maria Hastermann, Sonja Hochmeister, et al.. (2015). Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathologica. 130(6). 783–798. 57 indexed citations
14.
Chang, Eric H., Bruce T. Volpe, Meggan Mackay, et al.. (2015). Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor. EBioMedicine. 2(7). 755–764. 63 indexed citations
15.
Brimberg, Lior, Simone Mader, Yuichiro Fujieda, et al.. (2015). Antibodies as Mediators of Brain Pathology. Trends in Immunology. 36(11). 709–724. 44 indexed citations
16.
Sankowski, Roman, et al.. (2015). Systemic Inflammation and the Brain: Novel Roles of Genetic, Molecular, and Environmental Cues as Drivers of Neurodegeneration. Frontiers in Cellular Neuroscience. 9. 28–28. 255 indexed citations
17.
Kawakami, Naoto, Maja Kitic, Jan Bauer, et al.. (2013). T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathologica Communications. 1(1). 85–85. 73 indexed citations
18.
Dujmović, Irena, Simone Mader, Kathrin Schanda, et al.. (2011). Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders. Journal of Neuroimmunology. 234(1-2). 124–130. 38 indexed citations
19.
Pauli, Franziska Di, Simone Mader, Kevin Rostásy, et al.. (2010). Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clinical Immunology. 138(3). 247–254. 142 indexed citations
20.
Bradl, Monika, Tatsuro Misu, Toshiyuki Takahashi, et al.. (2009). Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo. Annals of Neurology. 66(5). 630–643. 451 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026